BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

MIV Therapeutics Inc. 

8765 Ash Street, Unit #1

Vancouver  British Columbia  V6P 6T3  Canada
Phone: 604-301-9545 Fax: 604-301-9546


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Medical Device






 Company News
MIV Therapeutics Inc. (MIVT) Featured in Cardiovascular Business News 10/24/2008 8:06:44 AM    More...
MIV Therapeutics Inc. (MIVT) Featured on Front Page of Medical Device Daily 10/23/2008 8:24:35 AM    More...
Update: JACC Intervention Publishes MIV Therapeutics Inc. (MIVT)'s VESTASYNC I Trial Preliminary Results 10/21/2008 8:23:04 AM    More...
MIV Therapeutics Inc. (MIVT) Announces Participation at TCT 2008 in Washington, D.C. 10/9/2008 12:45:29 PM    More...
MIV Therapeutics Inc. (MIVT) CEO, Dr. Mark Landy To Be Featured as Panelist at Medical Design & Manufacturing Minneapolis Conference 9/18/2008 9:56:28 AM    More...
MIV Therapeutics Inc. (MIVT) VESTAsync™ Drug-Eluting Stent Trials Progress 9/15/2008 9:54:22 AM    More...
MIV Therapeutics Inc. (MIVT) Announces Exchange Offer for Reg. S Shareholders in Europe 8/15/2008 8:48:30 AM    More...
MIV Therapeutics Inc. (MIVT) Announces Excellent Safety and Efficacy of VESTAsync(TM) Polymer-Free Drug-Eluting Stent at 12-Month Clinical Follow Up 8/5/2008 6:36:55 AM    More...
MIV Therapeutics Inc. (MIVT) to Present at the BMO Capital Markets Focus On Healthcare Conference 7/30/2008 9:59:13 AM    More...
MIV Therapeutics Inc. (MIVT) Provides Update on Its Next-Generation, Ultra-Thin Protea(TM) Stent Platform 7/16/2008 6:29:59 AM    More...
12345678910...